Acurx Pharmaceuticals, Inc. (ACXP) Social Stream
Acurx Pharmaceuticals Inc (ACXP) Price Targets From Analysts
Use the tables below to see what analysts covering Acurx Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued January 3, 2022
ACXP Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ACXP as an investment opportunity.
- In terms of how Acurx Pharmaceuticals Inc fares relative to all US stocks, note that its number of analysts covering the stock is higher than just about none of of that group.
- ACXP has a lower variance in analysts' estimates than almost 100% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, Acurx Pharmaceuticals Inc's average analyst price target is higher than 19.78% of them.
- Acurx Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 67.33% of Healthcare stocks.
In the Pharmaceutical Products industry, ACST, ABVC, and XTLB are the three stocks most similar to Acurx Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Is ACXP a Buy, Hold or Sell? See the POWR Ratings now!